Search for: "United States of America v. Usher et al" Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2017, 7:01 am by John Elwood
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
11 Oct 2023, 3:30 pm by Jacob Fishman
& Leila Barraza et al., Supreme Court Impacts in Public Health Law: 2022-2023, Journal of Law, Medicine & Ethics (forthcoming 2023) In another tumultuous term of the United States Supreme Court in 2022-2023 a series of cr [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]